Beyfortus (nirsevimab) is an FDA approved and American Academy of Pediatrics (AAP) recommended injection that helps prevent serious lung disease caused by Respiratory Syncytial Virus (RSV).

This monoclonal antibody shot is available for all infants younger than 8 months of age during RSV season (typically October through the end of March). It is also available for some children 8 months to 19 months of age who are at increased risk for severe RSV disease and who are entering their second RSV season. 

Infants under 8 months of age whose mothers received the RSV vaccine (Abrysvo) during the 32nd-36th weeks of pregnancy should be protected for the season and will not need to get Beyfortus (as long as the vaccine was given 2 weeks before delivery).

If you would like your child to get this recommended immunization, please contact your insurance company to ensure coverage, then call our office at 434-975-7777 to schedule an appointment. At this time, we can only offer Beyfortus at the Charlottesville (Rio Road) office, but will be offering it in the Crozet office soon.